Journal of Obesity and Metabolism
Open Access

Red blood cell enzymes; Neurological manifestations; Glucose-6-phosphate dehydrogenase (G6PD); Pyruvate kinase (PK); Hexokinase (HK); Diagnosis and treatment

Introduction

Deficits in red blood cell enzymes can have profound neurological consequences, encompassing a spectrum of manifestations from mild cognitive impairment to severe neurological deficits [1-3]. Red blood cell enzymes play essential roles in metabolic pathways critical for energy production and neurotransmitter synthesis in the central nervous system. Dysregulation or deficiency of these enzymes disrupts cellular homeostasis, leading to neuronal dysfunction and neurological impairment. Among the key red blood cell enzymes implicated in neurological disorders are glucose-6-phosphate dehydrogenase (G6PD), pyruvate kinase (PK), and hexokinase (HK). Deficiencies in these enzymes can result in metabolic derangements, oxidative stress, and impaired energy metabolism, contributing to the pathogenesis of various neurological conditions.

In this review, we aim to explore the diverse neurological manifestations associated with deficits in G6PD, PK, and HK enzymes [4]. We will discuss the underlying pathophysiological mechanisms, clinical presentations, diagnostic strategies, and treatment approaches for these enzyme deficiencies. Understanding the intricate interplay between red blood cell enzyme deficits and neurological dysfunction is essential for early recognition, accurate diagnosis, and effective management of these conditions. By elucidating the neurological consequences of deficits in red blood cell enzymes, this review seeks to provide insights into the complex relationships between metabolism and neurology [5]. Furthermore, it underscores the importance of interdisciplinary collaboration between hematologists, neurologists, and other healthcare providers to optimize care for individuals affected by these enzyme deficiencies and associated neurological disorders.

Methods and Materials

This study will be conducted as a retrospective cohort study [6]. Participants will be identified from medical records of patients with diagnosed deficits in red blood cell enzymes (G6PD, PK, HK) who presented with neurological symptoms. Patients of all ages with confirmed deficits in G6PD, PK, or HK enzymes. Patients with neurological symptoms attributed to these enzyme deficiencies. Patients with known neurological disorders unrelated to red blood cell enzyme deficits.

Relevant demographic information, medical history, and clinical presentation will be extracted from medical records. Laboratory results confirming deficits in G6PD, PK, or HK enzymes will be documented. Neurological symptoms and their severity will be recorded. Diagnostic tests such as neuroimaging, electroencephalography (EEG), and genetic testing will be noted [7]. Descriptive statistics will be used to summarize demographic data and clinical characteristics of the study population. The spectrum and prevalence of neurological manifestations associated with deficits in G6PD, PK, and HK enzymes will be analyzed. The association between enzyme deficiencies and specific neurological symptoms will be explored using appropriate statistical methods. Subgroup analyses may be conducted based on age, gender, and severity of enzyme deficiency.

This study will be conducted in accordance with the principles of the Declaration of Helsinki. Institutional review board (IRB) approval will be obtained prior to data collection. Patient confidentiality will be ensured by anonymizing data during analysis and reporting. Limitations of this study may include its retrospective design, potential selection bias, and reliance on existing medical records [8-10]. The generalizability of findings may be limited by the characteristics of the study population and the specific enzyme deficiencies evaluated. This study aims to provide valuable insights into the neurological manifestations of deficits in red blood cell enzymes, contributing to our understanding of the complex relationship between metabolism and neurology.

Conclusion

As this is a proposed study outline, a conclusion is not applicable. However, once the study has been conducted, analyzed, and interpreted, the conclusion would summarize the key findings and their implications. It would likely discuss the spectrum and prevalence of neurological manifestations associated with deficits in red blood cell enzymes (G6PD, PK, HK), as well as any identified associations between enzyme deficiencies and specific neurological symptoms. The conclusion would also highlight the clinical significance of these findings, potential implications for diagnosis and treatment, and directions for future research in this area.

Acknowledgement

None

Conflict of Interest

None

1. Diogo-Filho A, Maia CP, Diogo DM, Diogo PM, Vasconcelos PM, et al. (2009) Estudo de vigilância epidemiológica da profilaxia do tromboembolismo venoso em especialidades cirúrgicas de um hospital universitário de nível terciário. Arq Gastroenterol 46: 9-14.

Indexed at, Google Scholar, Crossref

2. Frisbie JH, Sharma GVRK (1994) Pulmonary embolism manifesting as acute disturbances of behavior in patients with spinal cord injury. Paraplegia 32: 570-2.

Indexed at, Google Scholar, Crossref

3. Khan F, Tritschler T, Kahn SR, Rodger MA (2021) Venous thromboembolism. The Lancet 398: 64-77.

Google Scholar

4. Paterson JC, McLachlin J (1954) Precipitating factors in venous thrombosis. Surg Gynecol Obstet. 98: 96-102.

Indexed at, Google Scholar

5. Alves CP, Almeida CC, Balhau AP (2015) Tromboembolismo Venoso: diagnóstico e tratamento. Portuguesa de Cirurgia Vascular 320: 1583-1594.

Indexed at, Google Scholar, Crossref

6. Ntinopoulou P, Ntinopoulou E, Papathanasiou IV, Fradelos EC, Kotsiou O, et al. (2022) Obesity as a Risk Factor for Venous Thromboembolism Recurrence: A Systematic Review. Medicina 58: 1290.

Indexed at, Google Scholar, Crossref

7. Mello NA, Duque FLV (2003) Trombogênese e Trombofilia. J Vasc Bras 2: 105-18.

Indexed at, Google Scholar, Crossref

8. Albuquerque HPC, Vidal PC (1996) Trombose venosa profunda: revisão dos conceitos atuais. Rev Bras Ortop 31: 10.

Google Scholar

9. Maffei FHA, Rollo HA (2016) Trombose venosa profunda dos membros inferiores. Incidência, patogenia, patologia, fisiopatologia e diagnóstico. Doenças Vasculares Periféricas 4: p.1776- 95.

Indexed at, Google Scholar

10. ES de Saude de Viseu, CI dos Santos Costa (2017) Medidas preventivas  do  tromboembolismo  venoso  no  doente  hospitalizado:  uma  revisão integrativa da literatura, fevereiro de 18: 209-20 .

Google Scholar